Information Library
Oncology - Phase II/III
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
ASCO 2010 Annual Meeting
June 4 - June 8, 2010
Exhibit Dates: June 5 - 7, 2010 Exhibitor Booth Number: 2053 -
Changing the Face of Cancer Research
August 31, 2009
Christopher Ung, Vice President, Strategic Business & Operations, Oncology, at TMD, a Quintiles Central Laboratory, explains how advances in biomarker technology are ushering in a new era of cancer therapy development. -
Sub-Saharan Africa Phase II/III Fact Sheet
July 29, 2009
Sub-Saharan Africa fact sheet about Phase II/III trials. The gateway to Africa: Access to expanded clinical resources and patient populations in South Africa and beyond. -
Validated Biomarker Menu
July 14, 2009
A comprehensive menu of validated cell, fluid and tissue based biomarker assays. -
Advanced Gastric Cancer
May 12, 2009
To meet the challenges in patient recruitment, Quintiles relied on its therapeutic experience and extensive global site network to select the study sites most likely to treat patients meeting study entry criteria. In order to assist oncologists in working with the primary-tumor-related inclusion criteria, CRAs provided training to all sites based on a radiological briefing document.
Page 1 of 1 (5 items)